Realbotix LLC Announces Bridge Loan from Onconetix

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Realbotix LLC Announces Bridge Loan from OnconetixAuthor of the article:Bridge loan strengthens Realbotix’s working capital position while the parties advance the proposed merger.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountLAS VEGAS — Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, announces that its wholly owned subsidiary, Realbotix LLC, has entered into a loan agreement with Onconetix, Inc. (“Onconetix”) for an unsecured bridge loan facility in connection with the proposed merger transaction involving Realbotix LLC and Onconetix previously announced on February 12, 2026.The bridge loan provides transaction-aligned working capital to Realbotix LLC while the parties advance the merger.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againOnconetix is the lender, Realbotix LLC is the borrower, and Realbotix Corp. provides a guarantee of payment under the note.The facility consists of an unsecured promissory note with an initial draw of US$2,500,000 and additional draws available up to an aggregate amount of US$5,000,000.The note is non-interest bearing. At closing of the merger, the note and all obligations under the loan documents will be automatically cancelled and discharged in full, without payment by Realbotix LLC or Realbotix Corp.If the merger agreement is terminated, interest accrues on the outstanding principal amount at 12% per annum from the date of termination.“The loan provides working capital for Realbotix LLC during the merger process, and preserves the economic alignment between Realbotix and Onconetix,” said Andrew Kiguel, CEO of Realbotix.The loan agreement contains customary limited representations and warranties, limited events of default, and a negative covenant restricting Realbotix LLC and Realbotix Corp. from incurring, assuming, guaranteeing, or otherwise becoming liable for additional indebtedness without Onconetix’s prior written consent. The loan is unsecured and does not require any security interest, lien, pledge, collateral assignment, UCC filing, or other collateral arrangement.Realbotix Corp. is a U.S. based innovator of humanoid robots and embodied AI systems designed for natural human interaction. Manufactured in the United States, Realbotix’s patented technologies enable lifelike facial expressions, fluid movement, vision systems, and advanced social engagement. The Company’s platforms are developed for applications in healthcare, education, service industries, and consumer markets. For more information, visit: Corporate and Investor siteKeep up-to-date on Realbotix developments by joining our online communities on Twitter, LinkedIn, and YouTube.Follow Aria, our humanoid robot, on X, Instagram, and TikTok.Forward-Looking Statements This news release contains forward-looking statements and information within the meaning of applicable securities laws, including management’s objectives, strategies, beliefs, and intentions. Forward-looking statements are often, but not always, identified by words such as “may,” “will,” “plan,” “expect,” “anticipate,” “estimate,” “intend,” “believe,” or similar expressions referring to future events or results.These forward-looking statements are based on management’s current opinions and expectations and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such statements.Readers are cautioned not to place undue reliance on forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.All forward-looking statements are subject to the risks and uncertainties detailed in the Company’s continuous disclosure filings available at www.sedarplus.ca. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.View source version on businesswire.com: This advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.